# Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water

> **NCT00768183** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KADIAN Capsule + alcohol (under fasting conditions)
- **DRUG:** KADIAN Capsule + water (under fasting conditions)
- **DRUG:** morphine sulfate IR oral solution + water
- **DRUG:** KADIAN Capsule + alcohol (under fed conditions)

## Key facts

- **NCT ID:** NCT00768183
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00768183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00768183, "Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00768183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*